Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus : implications for fitness cost and clinical prevalence
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkae468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Jie Ding und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, China. Hauptthemen laut MEDLINE: Amikacin, Mycobacterium abscessus, Anti-Bacterial Agents, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Objectives
Amikacin is crucial for treating Mycobacterium abscessus (Mab) infections, with resistance primarily attributed to rrs gene mutations. The correlation between specific mutations and amikacin susceptibility, along with the associated fitness cost, requires further investigation.
Methods
We isolated spontaneous amikacin-resistant mutants in vitro and identified their mutation sites in the rrs gene via Sanger sequencing, which were then compared with existing reports. Using CRISPR/Cas12a-assisted recombineering, we engineered Mab strains with specific rrs mutations. The growth rate and fitness costs in vitro were evaluated, in conjunction with drug susceptibility testing to determine the relationship between rrs mutations and amikacin resistance.
Results
The mutation frequency of Mab for amikacin resistance ranged from 4.68 × 10⁻⁷ to 9.38 × 10⁻⁹. Three rrs mutation sites (A1375G, C1376T, G1458T) were identified, with A1375G being the most prevalent. Two additional sites, T1373A and T1465A, have been reported previously but not detected in this study. The five gene-edited strains demonstrated resistance to amikacin and cross-resistance to other aminoglycosides, and all exhibited slower in vitro growth rates than the wild-type Mab. Competitive experiments revealed that T1373A and T1465A have high fitness costs, while C1376T and G1458T have weak fitness costs and A1375G shows no fitness costs.
Conclusions
Our findings confirm that rrs mutations confer high-level amikacin resistance, with the limited mutation spectrum in clinical isolates possibly linked to higher spontaneous mutation frequency and lower fitness costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, China.
- State Key Laboratory of Respiratory Disease, China-New Zealand Joint Laboratory on Biomedicine and Health, Institute of Drug Discovery, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangz…
- University of Chinese Academy of Sciences, Beijing 100049, China.
- State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou, Guangdong 510095, China.
- School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- Guangzhou Institute of Respiratory Diseases
- First Affiliated Hospital of Guangzhou Medical University
- Joint Research Health Research Council of New Zealand
- NSFC Collaboration
- Chinese Academy of Sciences
Zitieren
APA
Ding, J., Hameed, H. M. A., Long, L., Zhang, J., Fang, C., Tian, X., Zhang, H., Li, L., Li, C., Yang, R., Gao, Y., Wang, S., & Zhang, T. (2025). Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus : implications for fitness cost and clinical prevalence. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae468
Vancouver
Ding J, Hameed HMA, Long L, Zhang J, Fang C, Tian X, et al. Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus : implications for fitness cost and clinical prevalence. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae468
BibTeX
@article{Ding2025,
author = {Ding, Jie and Hameed, H M Adnan and Long, Lihua and Zhang, Jingran and Fang, Cuiting and Tian, Xirong and Zhang, Han and Li, Lijie and Li, Chunyu and Yang, Ruhao and Gao, Yamin and Wang, Shuai and Zhang, Tianyu},
title = {Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus : implications for fitness cost and clinical prevalence},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkae468}
}
EUVIMED